(2'-(4-aminophenyl)-(2,5'-bi-1H-benzimidazol)-5-amine),
RO 90-7501,
Ro 90-7501,
293762-45-5,
GNF-Pf-5510,
[2,5'-Bi-1H-benzimidazol]-5-amine, 2'-(4-aminophenyl)-,
2'-(4-Amino-phenyl)-3H,3'H-[2,5']bibenzoimidazolyl-5-ylamine,
CBChromo1_000149,
AC1LGN68,
Cambridge id 5180073,
CBDivE_006377,
CHEMBL578741,
SCHEMBL10002475,
CHEBI:93018,
CTK8E9490,
DTXSID80356431,
HMS3262E21,
HMS3269A19,
HMS3677K16,
Tox21_500670,
STK367782,
ZINC18206988,
AKOS000635167,
AKOS001483260,
CCG-221974,
LP00670,
MCULE-7528949788,
NCGC00094031-01,
NCGC00094031-02,
NCGC00094031-03,
NCGC00094031-04,
NCGC00094031-05,
NCGC00094031-06,
NCGC00261355-01,
ACM293762455,
BAS 03420670,
ST078196,
RT-015428,
B7043,
A12647,
AB00074940-01,
Ro 90-7501, >=98% (HPLC),
AG-690/09405007,
SR-01000389409,
J-017493,
SR-01000389409-1,
BRD-K58299615-001-02-7,
2'-(4-aminophenyl)-[2,5'-bi-1H-benzimidazol]-5-amine,
2'-(4-aminophenyl)-1H,1'H-2,5'-bibenzimidazol-5-amine,
2-[2-(4-aminophenyl)benzimidazol-6-yl]benzimidazole-6-ylamine,
2-[2-(4-aminophenyl)-3H-benzimidazol-5-yl]-3H-benzimidazol-5-amine,
2 inverted exclamation marka-(4-Aminophenyl)-[2,5 inverted exclamation marka-bi-1H-benzimidazol]-5-amine,
PAGZCEHLFCJSPV-UHFFFAOYSA-N,
C20H16N6,
CID824226,
ZINC04579250,